Featured Research

from universities, journals, and other organizations

Drug resistance in metastatic melanoma: New insight

Date:
June 3, 2014
Source:
Manchester University
Summary:
A study has shown how melanoma drugs can cause cancer to progress once a patient has stopped responding to treatment. The findings suggest that using a combination of targeted therapies may be a more effective approach in the clinic.

A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.

Their findings suggest that using a combination of targeted therapies may be a more effective approach in the clinic.

Melanoma is a form of cancer that develops from melanocytes -- the pigment-producing cells in skin. Advanced metastatic melanoma -- where the cancer has spread throughout the body -- is associated with poor survival, so new treatments are urgently needed.

In about 50% of melanoma cases, the tumour contains a mutation in a gene known as BRAF. Drugs that target BRAF -- such as vemurafenib -- have increased survival in patients with this mutation. However, many of these patients go on to develop resistance to treatment and their disease returns.

Now researchers from the Cancer Research UK Manchester Institute at The University of Manchester -- part of the Manchester Cancer Research Centre -- have explored what happens in melanoma cells following inhibition of BRAF.

Professor Richard Marais, who led the research, said: "BRAF inhibitors have improved survival for patients with metastatic melanoma. Unfortunately, eventual drug resistance is preventing long-term cure in most of these patients. We wanted to understand how these drugs might induce unwanted effects in melanoma cells -- particularly in cells which also have a mutation in the RAS gene."

The group found that blocking BRAF activity, either using drugs or by altering a cell's genes, led to the RAS-mutated melanoma cells changing shape and becoming more invasive. These changes in behaviour would lead to metastatic spread of the disease throughout the body.

Their study, published recently in the journal Science Signaling, showed that the BRAF inhibitors re-activated certain pathways within cells leading to melanoma cells becoming resistant to therapy.

"We found that we could counteract this behaviour by adding a second drug to the BRAF inhibitor -- one that targets MEK. It looks like our study further supports the combined use of both BRAF and MEK inhibitors in melanoma patients," added Professor Marais.


Story Source:

The above story is based on materials provided by Manchester University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Richard Marais et al. BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells by Reactivating MEK and ERK Signaling. Science Signaling, June 2014 DOI: 10.1126/scisignal.2004815]

Cite This Page:

Manchester University. "Drug resistance in metastatic melanoma: New insight." ScienceDaily. ScienceDaily, 3 June 2014. <www.sciencedaily.com/releases/2014/06/140603092330.htm>.
Manchester University. (2014, June 3). Drug resistance in metastatic melanoma: New insight. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2014/06/140603092330.htm
Manchester University. "Drug resistance in metastatic melanoma: New insight." ScienceDaily. www.sciencedaily.com/releases/2014/06/140603092330.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins